Cargando…

Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania

OBJECTIVE: This study assessed impaired fasting glucose and associated factors among perinatally HIV-infected adolescents and youths in Dar es salaam Tanzania. BACKGROUND: Impaired fasting glucose is a marker of heightened risk for developing type 2 diabetes among perinatally HIV-infected individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Nkinda, Lilian, Buberwa, Eliud, Memiah, Peter, Ntagalinda, Alieth, George, Martin, Msafiri, Frank, Joachim, Agricola, Majigo, Mtebe, Ramaiya, Kaushik, Sunguya, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763284/
https://www.ncbi.nlm.nih.gov/pubmed/36561566
http://dx.doi.org/10.3389/fendo.2022.1045628
_version_ 1784853022638080000
author Nkinda, Lilian
Buberwa, Eliud
Memiah, Peter
Ntagalinda, Alieth
George, Martin
Msafiri, Frank
Joachim, Agricola
Majigo, Mtebe
Ramaiya, Kaushik
Sunguya, Bruno
author_facet Nkinda, Lilian
Buberwa, Eliud
Memiah, Peter
Ntagalinda, Alieth
George, Martin
Msafiri, Frank
Joachim, Agricola
Majigo, Mtebe
Ramaiya, Kaushik
Sunguya, Bruno
author_sort Nkinda, Lilian
collection PubMed
description OBJECTIVE: This study assessed impaired fasting glucose and associated factors among perinatally HIV-infected adolescents and youths in Dar es salaam Tanzania. BACKGROUND: Impaired fasting glucose is a marker of heightened risk for developing type 2 diabetes among perinatally HIV-infected individuals. Therefore, identifying individuals at this stage is crucial to enable early intervention. Therefore, we assessed impaired fasting glucose (IFG) and associated factors among perinatally HIV-infected population in Dar es salaam Tanzania. METHODS: A cross-sectional study was conducted among 152 adolescents and youth attending HIV clinic at Muhimbili National Hospital and Infectious Disease Centre from July to August 2020. Fasting blood glucose (>8 hours) was measured using one-touch selects LifeScan, CA, USA. We also examined C-Reactive Protein and interleukin-6 inflammatory biomarkers in relation to impaired fasting glucose (IFG). Associations between categorical variables were explored using Chi-square, and poison regression with robust variance was used to calculate the prevalence ratios. RESULTS: Of the 152 participants, the majority were male (n=83[54.6%]), and the median age was 15(14-18) years. Overweight or obesity was prevalent in 16.4%, while more than one in ten (13.2%) had high blood pressure (≥149/90mmHg). All participants were on antiretroviral therapy (ART); 46% had used medication for over ten years, and about one in three had poor medication adherence. Among the recruited participants, 29% had impaired fasting glucose. The odds of IFG were two times higher in males compared to females (PR, 2.07, 95% CI 1.19 -3.59 p=0.001). Moreover, we found with every increase of Interleukin 6 biomarker there was a 1.01 probability increase of impaired fasting glucose (PR, 1.01, 95% CI 1.00 – 1.02 p=0.003). CONCLUSION: About one in three perinatally HIV-infected youths had impaired fasting glucose in Dar es Salaam, Tanzania, with males bearing the biggest brunt. Moreover, with every increase of 1.101 of the probability of having IFG increased. This calls for urgent measures to interrupt the progression to diabetes disease and prevent the dual burden of disease for this uniquely challenged population.
format Online
Article
Text
id pubmed-9763284
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97632842022-12-21 Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania Nkinda, Lilian Buberwa, Eliud Memiah, Peter Ntagalinda, Alieth George, Martin Msafiri, Frank Joachim, Agricola Majigo, Mtebe Ramaiya, Kaushik Sunguya, Bruno Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: This study assessed impaired fasting glucose and associated factors among perinatally HIV-infected adolescents and youths in Dar es salaam Tanzania. BACKGROUND: Impaired fasting glucose is a marker of heightened risk for developing type 2 diabetes among perinatally HIV-infected individuals. Therefore, identifying individuals at this stage is crucial to enable early intervention. Therefore, we assessed impaired fasting glucose (IFG) and associated factors among perinatally HIV-infected population in Dar es salaam Tanzania. METHODS: A cross-sectional study was conducted among 152 adolescents and youth attending HIV clinic at Muhimbili National Hospital and Infectious Disease Centre from July to August 2020. Fasting blood glucose (>8 hours) was measured using one-touch selects LifeScan, CA, USA. We also examined C-Reactive Protein and interleukin-6 inflammatory biomarkers in relation to impaired fasting glucose (IFG). Associations between categorical variables were explored using Chi-square, and poison regression with robust variance was used to calculate the prevalence ratios. RESULTS: Of the 152 participants, the majority were male (n=83[54.6%]), and the median age was 15(14-18) years. Overweight or obesity was prevalent in 16.4%, while more than one in ten (13.2%) had high blood pressure (≥149/90mmHg). All participants were on antiretroviral therapy (ART); 46% had used medication for over ten years, and about one in three had poor medication adherence. Among the recruited participants, 29% had impaired fasting glucose. The odds of IFG were two times higher in males compared to females (PR, 2.07, 95% CI 1.19 -3.59 p=0.001). Moreover, we found with every increase of Interleukin 6 biomarker there was a 1.01 probability increase of impaired fasting glucose (PR, 1.01, 95% CI 1.00 – 1.02 p=0.003). CONCLUSION: About one in three perinatally HIV-infected youths had impaired fasting glucose in Dar es Salaam, Tanzania, with males bearing the biggest brunt. Moreover, with every increase of 1.101 of the probability of having IFG increased. This calls for urgent measures to interrupt the progression to diabetes disease and prevent the dual burden of disease for this uniquely challenged population. Frontiers Media S.A. 2022-12-06 /pmc/articles/PMC9763284/ /pubmed/36561566 http://dx.doi.org/10.3389/fendo.2022.1045628 Text en Copyright © 2022 Nkinda, Buberwa, Memiah, Ntagalinda, George, Msafiri, Joachim, Majigo, Ramaiya and Sunguya https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Nkinda, Lilian
Buberwa, Eliud
Memiah, Peter
Ntagalinda, Alieth
George, Martin
Msafiri, Frank
Joachim, Agricola
Majigo, Mtebe
Ramaiya, Kaushik
Sunguya, Bruno
Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania
title Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania
title_full Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania
title_fullStr Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania
title_full_unstemmed Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania
title_short Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania
title_sort impaired fasting glucose levels among perinatally hiv-infected adolescents and youths in dar es salaam, tanzania
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763284/
https://www.ncbi.nlm.nih.gov/pubmed/36561566
http://dx.doi.org/10.3389/fendo.2022.1045628
work_keys_str_mv AT nkindalilian impairedfastingglucoselevelsamongperinatallyhivinfectedadolescentsandyouthsindaressalaamtanzania
AT buberwaeliud impairedfastingglucoselevelsamongperinatallyhivinfectedadolescentsandyouthsindaressalaamtanzania
AT memiahpeter impairedfastingglucoselevelsamongperinatallyhivinfectedadolescentsandyouthsindaressalaamtanzania
AT ntagalindaalieth impairedfastingglucoselevelsamongperinatallyhivinfectedadolescentsandyouthsindaressalaamtanzania
AT georgemartin impairedfastingglucoselevelsamongperinatallyhivinfectedadolescentsandyouthsindaressalaamtanzania
AT msafirifrank impairedfastingglucoselevelsamongperinatallyhivinfectedadolescentsandyouthsindaressalaamtanzania
AT joachimagricola impairedfastingglucoselevelsamongperinatallyhivinfectedadolescentsandyouthsindaressalaamtanzania
AT majigomtebe impairedfastingglucoselevelsamongperinatallyhivinfectedadolescentsandyouthsindaressalaamtanzania
AT ramaiyakaushik impairedfastingglucoselevelsamongperinatallyhivinfectedadolescentsandyouthsindaressalaamtanzania
AT sunguyabruno impairedfastingglucoselevelsamongperinatallyhivinfectedadolescentsandyouthsindaressalaamtanzania